Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02406820 · ClinicalTrials.gov registry record
Correlating Noninvasive Cardiovascular Measures to Left Ventricular End Diastolic Pressure in Heart Failure
A clinical trial, sponsored by Intelomed.
- Terminated
- Registry status
- 1
- Enrollment target
NCT02406820 is a clinical trial that was terminated before completion, run by Intelomed. The registered enrollment target is 1 participants.
The verdict
NCT02406820 was terminated before completion, sponsored by Intelomed.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
HF001 is a prospective observational study utilizing non-invasive medical devices that may be able to discriminate changes in heart failure while acutely decompensated patients undergo routine interventional therapies in a hospital setting. Subjects will be monitored using CVInsight™ \[CVI\] via a finger and/or forehead sensor, while performing an isometric handgrip stress test (IHGST). Changes in the CVI signal will be analyzed and correlated to standard assessments of heart failure including pulmonary artery catheter (PAC) pressures, blood pressure (BP), patient symptoms, and physical exam findings. The results of this study will be used to develop a powered study to determine if a new configuration of non-invasive monitoring devices can be used to monitor heart failure status more sensitively than current non-invasive techniques.
Interventions
- DEVICE Non-invasive hemodynamic monitoring (CVInsight™ [CVI])
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02406820
The ClinicalTrials.gov registry entry for NCT02406820 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intelomed, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-invasive hemodynamic monitoring (CVInsight™ [CVI]) is the first listed.
NCT02406820 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02406820 about?
NCT02406820 is a clinical study titled "Correlating Noninvasive Cardiovascular Measures to Left Ventricular End Diastolic Pressure in Heart Failure". HF001 is a prospective observational study utilizing non-invasive medical devices that may be able to discriminate changes in heart failure while acutely decompensated patients undergo routine interventional therapies in a hospital setting. Subjects will be monitored using CVInsight™ \[CVI\] via a f...
What is the current status of trial NCT02406820?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2015-04. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02406820?
The interventions under investigation include: Non-invasive hemodynamic monitoring (CVInsight™ [CVI]) (DEVICE).
Who is sponsoring clinical trial NCT02406820?
This trial is sponsored by Intelomed, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.